LEUKOSCAN

This brand name is authorized in Lithuania, Spain.

Active ingredients

The drug LEUKOSCAN contains one active pharmaceutical ingredient (API):

1	Technetium ⁹⁹ᵐTc sulesomab UNII 0G1945O6IB - SULESOMAB TECHNETIUM TC-99M
	Technetium ⁹⁹ᵐTc sulesomab (IMMU-MN3 murine Fab′-SH antigranulocyte monoclonal antibody fragments) recognizes an antigenic structure shared by a surface glycoprotein (NCA-90) of granulocytes and the tumour marker. It is indicated for diagnostic imaging for determining the location and extent of infection/inflammation in bone in patients with suspected osteomyelitis, including patients with diabetic foot ulcers.
	Read more about Technetium ⁹⁹ᵐTc sulesomab

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
LEUKOSCAN Powder for solution for injection	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
V09HA04	Technetium (99mTc) sulesomab	V Various → V09 Diagnostic radiopharmaceuticals → V09H Inflammation and infection detection → V09HA Technetium (99mTc) compounds
Discover more medicines within V09HA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
ES	Centro de información online de medicamentos de la AEMPS	98032001
LT	Valstybinė vaistų kontrolės tarnyba	1029389